| Omega Therapeutics Lands $85M to Tap Into “Control Room” of Biology | Frank Vinluan | 07/29/20 | Boston |
| Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More | Frank Vinluan | 06/19/20 | National |
| FDA Pumps the Brakes on Epizyme’s Top Cancer Drug Tazemetostat | Alex Lash | 04/23/18 | Boston |
| Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More | Ben Fidler | 06/24/16 | National |
| Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug | Ben Fidler | 06/19/16 | Boston |
| Epizyme Extends Celgene Cancer Deal for $10M Upfront | David Holley | 07/09/15 | Boston |
| East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More | Ben Fidler | 06/26/15 | Boston |
| Epizyme Shares Climb on New Data for Cancer Drug | Ben Fidler | 06/22/15 | Boston |
